Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

389 related articles for article (PubMed ID: 29492793)

  • 1. Risk of second malignancies among survivors of pediatric thyroid cancer.
    Adly MH; Sobhy M; Rezk MA; Ishak M; Afifi MA; Shafie AE; Ali MA; Zekri W; Alfaar AS; Rashed WM
    Int J Clin Oncol; 2018 Aug; 23(4):625-633. PubMed ID: 29492793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased risk of second primary malignancy in pediatric and young adult patients treated with radioactive iodine for differentiated thyroid cancer.
    Marti JL; Jain KS; Morris LG
    Thyroid; 2015 Jun; 25(6):681-7. PubMed ID: 25851829
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rising incidence of second cancers in patients with low-risk (T1N0) thyroid cancer who receive radioactive iodine therapy.
    Iyer NG; Morris LG; Tuttle RM; Shaha AR; Ganly I
    Cancer; 2011 Oct; 117(19):4439-46. PubMed ID: 21432843
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Italian cancer figures, report 2013: Multiple tumours.
    AIRTUM Working Group
    Epidemiol Prev; 2013; 37(4-5 Suppl 1):1-152. PubMed ID: 24259384
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Risk of second primary malignancy in differentiated thyroid carcinoma treated with radioactive iodine therapy.
    Lang BH; Wong IO; Wong KP; Cowling BJ; Wan KY
    Surgery; 2012 Jun; 151(6):844-50. PubMed ID: 22341041
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Risk of thyroid cancer in survivors of childhood cancer: results from the British Childhood Cancer Survivor Study.
    Taylor AJ; Croft AP; Palace AM; Winter DL; Reulen RC; Stiller CA; Stevens MC; Hawkins MM
    Int J Cancer; 2009 Nov; 125(10):2400-5. PubMed ID: 19610069
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pediatric thyroid cancer: An update from the SEER database 2007-2012.
    Dermody S; Walls A; Harley EH
    Int J Pediatr Otorhinolaryngol; 2016 Oct; 89():121-6. PubMed ID: 27619041
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thyroid carcinoma in children and adolescents.
    Danese D; Gardini A; Farsetti A; Sciacchitano S; Andreoli M; Pontecorvi A
    Eur J Pediatr; 1997 Mar; 156(3):190-4. PubMed ID: 9083757
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The risk of second primary malignancies up to three decades after the treatment of differentiated thyroid cancer.
    Brown AP; Chen J; Hitchcock YJ; Szabo A; Shrieve DC; Tward JD
    J Clin Endocrinol Metab; 2008 Feb; 93(2):504-15. PubMed ID: 18029468
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased risk of certain second primary malignancies in patients treated for well-differentiated thyroid cancer.
    Hakala TT; Sand JA; Jukkola A; Huhtala HS; Metso S; Kellokumpu-Lehtinen PL
    Int J Clin Oncol; 2016 Apr; 21(2):231-239. PubMed ID: 26410770
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Non-Small Cell Lung Cancer as a Second Primary Among Patients With Previous Malignancy: Who Is at Risk?
    Wu GX; Nelson RA; Kim JY; Raz DJ
    Clin Lung Cancer; 2017 Sep; 18(5):543-550.e3. PubMed ID: 28412093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Risk of a second malignant neoplasm among 5-year survivors of cancer in childhood and adolescence in British Columbia, Canada.
    MacArthur AC; Spinelli JJ; Rogers PC; Goddard KJ; Phillips N; McBride ML
    Pediatr Blood Cancer; 2007 Apr; 48(4):453-9. PubMed ID: 16767718
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased risk of second malignant neoplasms in adolescents and young adults with cancer.
    Lee JS; DuBois SG; Coccia PF; Bleyer A; Olin RL; Goldsby RE
    Cancer; 2016 Jan; 122(1):116-23. PubMed ID: 26441212
    [TBL] [Abstract][Full Text] [Related]  

  • 14. External radiotherapy of thyroid cancer.
    Pöllinger B; Dühmke E
    Onkologie; 2001 Apr; 24(2):134-8. PubMed ID: 11441292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [CME: Radioactive iodine therapy in thyroid cancer].
    Steinert HC; Aberle S
    Praxis (Bern 1994); 2015 Nov; 104(23):1235-43; quiz 1244-5. PubMed ID: 26558927
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk of Second Primary Malignancies in Patients With Follicular Lymphoma: A United States Population-based Study.
    Giri S; Bhatt VR; Verma V; Pathak R; Bociek RG; Vose JM; Armitage JO
    Clin Lymphoma Myeloma Leuk; 2017 Sep; 17(9):569-574. PubMed ID: 28709798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Risk of selected subsequent carcinomas in survivors of childhood cancer: a report from the Childhood Cancer Survivor Study.
    Bassal M; Mertens AC; Taylor L; Neglia JP; Greffe BS; Hammond S; Ronckers CM; Friedman DL; Stovall M; Yasui YY; Robison LL; Meadows AT; Kadan-Lottick NS
    J Clin Oncol; 2006 Jan; 24(3):476-83. PubMed ID: 16421424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of second primary malignancy after radioactive iodine treatment for differentiated thyroid carcinoma.
    Bhattacharyya N; Chien W
    Ann Otol Rhinol Laryngol; 2006 Aug; 115(8):607-10. PubMed ID: 16944659
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk of soft tissue sarcomas by individual subtype in survivors of hereditary retinoblastoma.
    Kleinerman RA; Tucker MA; Abramson DH; Seddon JM; Tarone RE; Fraumeni JF
    J Natl Cancer Inst; 2007 Jan; 99(1):24-31. PubMed ID: 17202110
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Risk of second primary cancer after treatment for esophageal cancer: a pooled analysis of nine cancer registries.
    Zhu G; Chen Y; Zhu Z; Lu L; Bi X; Deng Q; Chen X; Su H; Liu Y; Guo H; Zheng T; Yu H; Zhang Y
    Dis Esophagus; 2012 Aug; 25(6):505-11. PubMed ID: 22067063
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.